Jubilant Ingrevia Q3 Net Profit Drops 32% YoY Amid Pricing Pressures
NiveshIQ
NSE: JUBLINGREA · Chemicals
Jubilant Ingrevia Ltd.
₹658.40▼ ₹8.20 (-1.23%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on JUBLINGREA. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Jubilant Ingrevia Ltd.
Jubilant Ingrevia Limited operates across three core segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates, generating a total revenue of ₹4,650 crore in FY24. The Specialty Chemicals arm drives the bulk of sales with bio‑pyridine, fine chemicals, agro‑chemicals, and custom manufacturing services, while the Nutrition & Health Solutions segment supplies animal and human nutrition ingredients, vitamins, and herbal growth promoters. The Chemical Intermediates division supplies key industrial chemicals such as acetic anhydride, bio‑acetic acid, and ethyl acetate, catering to pharmaceutical and agro‑chemical customers. Recent Q3 results showed a 32% year‑on‑year decline in net profit due to pricing pressures, yet the company has announced a 250% dividend for FY
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹4,135 Cr +79.50% | ₹4,177 Cr +1.00% | ₹4,388 Cr +5.10% |
| EBITDA Margin | 10.21% | 12.43% | 13.85% |
| Net Profit | ₹183.00 Cr +27.10% | ₹251.00 Cr +37.20% | ₹291.13 Cr +16.00% |
| EPS | ₹11.49 | ₹15.77 | ₹17.59 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Jubilant Agri unsecured creditors approve demerger scheme unanimously
Breakout stocks by Geojit: Jubilant Ingrevia, ASK Automotive, KPR Mill
🔒
+ 3 more stories about Jubilant Ingrevia Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹1, 300 Cr, PAT ₹106 Cr, EPS ₹6.70, EBITDA margin 16.1%. Growth context: revenue QoQ +10.3%, PAT QoQ +22.4%. Street verdict: inline, revenue surprise +3.0%, PAT surprise +0.1%.
Recent corporate activity highlights R&D investments and technology initiatives as the primary near-term growth lever, w...
FY26 (last completed FY): revenue ₹4, 388 Cr, PAT ₹291 Cr, EBITDA margin 13.8%, EPS ₹17.59. Year-on-year: revenue YoY +5...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for JUBLINGREA
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track JUBLINGREA alongside your other holdings
Unlock full JUBLINGREA research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Jubilant Ingrevia Ltd.?
NiveshIQ detects active intelligence signals for Jubilant Ingrevia Ltd. (JUBLINGREA) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Jubilant Ingrevia Ltd.?
Jubilant Ingrevia Ltd. operates in the Chemicals sector with a market capitalisation of ₹1,170,256.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.